| Centers | ||
| Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | UCSC Chemical Screening Center | Presude Life Sciences | 
| Chulalongkorn
 Drug Discovery and Drug Development Research Center (Chula4DR) was 
established in 2017, with the aim to facilitate advancement of academic 
drug discovery and drug development research by leveraging innovations 
and  sciences...Read more | We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... | Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience.Read more Presude is a research driven company with expertise in medicinal chemistry, custom synthesis and... | 
| Partnerships | Events | Jobs | 
| Evotec and Yale University to collaborate on cancer therapyEvotec announced a research collaboration, TargetDBR (DNA Break Repair), with the laboratories of Prof. Peter Glazer and Prof. Ranjit Bindra at Yale School of Medicine. The objective of this collaboration is to identify novel mechanisms, targets and... View all Research collaboration and license agreementThe University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease. This announcement builds upon... View all Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								